Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals develops investigational therapies for endocrine conditions and neurodegenerative diseases.
SCHEDULE 13G/ANov 16Latest SEC filing
Nov 5Latest story
November 2026
September 2026
August 2026
Amylyx Pharmaceuticals develops investigational therapies for endocrine conditions and neurodegenerative diseases.
November 2026
September 2026
August 2026